"10.1371_journal.pone.0109430","plos one","2014-10-15T00:00:00Z","Mogens K Boisen; Christian Dehlendorff; Dorte Linnemann; Boye S Nielsen; Jim S Larsen; Kell Østerlind; Svend E Nielsen; Line S Tarpgaard; Camilla Qvortrup; Per Pfeiffer; Niels H Holländer; Nina Keldsen; Torben F Hansen; Brita B Jensen; Estrid V S Høgdall; Benny V Jensen; Julia S Johansen","Department of Oncology, Herlev University Hospital, Herlev, Denmark; Statistics, Bioinformatics and Registry, Danish Cancer Society Research Center, Copenhagen, Denmark; Department of Pathology, Herlev University Hospital, Herlev, Denmark; Bioneer, Hørsholm, Denmark; Department of Oncology, Roskilde Hospital, Roskilde, Denmark; Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Oncology and Palliation, Hillerød Hospital, Hillerød, Denmark; Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Oncology, Næstved Hospital, Næstved, Denmark; Department of Oncology, Herning Hospital, Herning, Denmark; Department of Oncology, Vejle Hospital, Vejle, Denmark; Department of Medicine, Queen Ingrid Hospital, Nuuk, Greenland; Department of Oncology, Sydvestjysk Hospital, Esbjerg, Denmark; Department of Medicine, Herlev University Hospital, Herlev, Denmark","Conceived and designed the experiments: MKB CD DL BSN EVSH BVJ JSJ. Analyzed the data: MKB CD DL BSN JSL KØ SEN LST CQ PP NHH NK TFH BBJ EVSH BVJ JSJ. Contributed reagents/materials/analysis tools: MKB CD DL BSN JSL KØ SEN LST CQ PP NHH NK TFH BBJ EVSH BVJ JSJ. Wrote the paper: MKB CD DL BSN JSL KØ SEN LST CQ PP NHH NK TFH BBJ EVSH BVJ JSJ.","The authors have read the journals policy and the authors of this manuscript have the following competing interests: BVJ: Roche, consultant/advisory role; SEN: Roche, consultant/advisory role; PP: Roche, consultant/advisory role; JSJ: Roche, honoraria and research funding; MKB: Roche, research funding. JSJ and MKB are co-inventors on a patent-application related to the mentioned miRNAs. Patent application info: Name Micrornas for prediction of treatment efficacy and prognosis of cancer patients; Application number PCT/DK2013/050015. BSN is employed by a commercial company (Bioneer). This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","10","Mogens K Boisen","MKB",17,TRUE,7,NA,17,17,TRUE,TRUE,FALSE,0,NA,FALSE
